Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Biantong
- Development stage
- Unknown
- Lead developer
- Jiangsu Shenqu Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xiao'er Biantong (also known as Xiao'er Tongbian) is a traditional Chinese patent medicine formulated as granules, composed of seven herbal ingredients: Houpo (*Magnolia officinalis* bark), LaiFuZi (*Raphanus sativus* seed), XingRen (*Armeniaca sibirica* seed), LuHui (*Aloe vera*), JueMingZi (*Cassia obtusifolia* seed), ZhiQiao (*Citrus aurantium* fruit), and BaiZhu (*Atractylodes macrocephala* rhizome). It was originally developed by Jiangsu Shenqu Pharmaceutical and is currently developed and manufactured by Jumpcan Pharmaceutical. Xiao'er Biantong is indicated for the treatment of functional constipation in children, particularly those diagnosed with food accumulation syndrome according to traditional Chinese medicine principles. The granules work by strengthening the spleen and stomach, promoting qi movement, relieving stagnation, and moistening the intestines to facilitate bowel movements. In clinical trials, Xiao'er Biantong demonstrated superior efficacy compared to placebo in increasing the frequency of spontaneous bowel movements and was well tolerated in pediatric patients. It was approved in China in August 2026 under the name Xiao'er Tongbian Granules.
- Other names
- XEBTXEBT granulesXiao'er Biantong GranuleXiao'er Biantong GranulesXiao'er Tongbian GranuleXiao'er Tongbian Granules
Beyond the preview
Go deeper on Xiao'er Biantong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiao'er Biantong.